---
title: "Ironwood Pharmaceuticals Executives Sell Shares for Tax Obligations"
date: "2025-02-13 10:10:01"
summary: "Reporter NameRelationshipTypeAmountSEC FilingMartini Gregory S.Chief Financial OfficerSell$21,211Form 4Silver RonaldPrincipal Accounting OfficerSell$21,204Form 4Mccourt Thomas AChief Executive OfficerSell$244,752Form 4Several executives at Ironwood Pharmaceuticals have recently sold shares of the company's Class A Common Stock to cover tax withholding obligations related to the vesting of restricted stock units. Gregory S. Martini, the Chief..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

| Reporter Name | Relationship | Type | Amount | SEC Filing |
| --- | --- | --- | --- | --- |
| Martini Gregory S. | Chief Financial Officer | Sell | $21,211 | [Form 4](https://www.sec.gov/Archives/edgar/data/2053936/000095017025019233/xslF345X05/ownership.xml) |
| Silver Ronald | Principal Accounting Officer | Sell | $21,204 | [Form 4](https://www.sec.gov/Archives/edgar/data/1873731/000095017025019236/xslF345X05/ownership.xml) |
| Mccourt Thomas A | Chief Executive Officer | Sell | $244,752 | [Form 4](https://www.sec.gov/Archives/edgar/data/1478448/000095017025019237/xslF345X05/ownership.xml) |

Several executives at Ironwood Pharmaceuticals have recently sold shares of the company's Class A Common Stock to cover tax withholding obligations related to the vesting of restricted stock units.

Gregory S. Martini, the Chief Financial Officer, sold 12,052 shares on February 10, 2025, at a weighted average price of $1.76 per share, totaling $21,211. Following this sale, Martini directly owns 183,810 shares of the company.

Ronald Silver, Principal Accounting Officer, sold 12,048 shares on the same date at the same price, with a total sale amount of $21,204. Post-transaction, Silver's direct ownership stands at 279,655 shares.

Thomas A. McCourt, the Chief Executive Officer and Director, sold 139,064 shares, also on February 10, 2025, at the weighted average price of $1.76 per share, resulting in a total of $244,752 from the sale. After this sale, McCourt directly owns 1,160,634 shares of Ironwood Pharmaceuticals.

[TradingView](https://www.tradingview.com/news/tradingview:10b04caec8228:0-ironwood-pharmaceuticals-executives-sell-shares-for-tax-obligations/)
